 |
Gewahlte Kriterien:
Fondstyp: Aktienfonds
| Anlageregion: weltweit
| Unterkategorie: Biotechnologie
|
Sortiert nach:
Fund Name |
Suche ändern
Neue Suche |
| |
|
| Klicken Sie auf eine Spaltenüberschrift, um zu sortieren. |
|
|
848186 | ALLIANZ BIOTECHNOLOGIE - A - EUR | EUR | 225,18 | 22.5. |   | -0,95 | 32,75 | 15,84 | 22,89 |  | A2DU17 | ALLIANZ BIOTECHNOLOGIE - P - EUR | EUR | 1,121,82 | 22.5. | | -0,57 | 34,06 | 18,29 | - | | A2AMPU | ALLIANZ BIOTECHNOLOGIE - R - EUR | EUR | 171,13 | 22.5. | | -0,61 | 33,92 | 18,85 | 28,29 | | A0RPSN | BELLEVUE FUNDS (LUX) - BELLEVUE OBESITY SOLUTIONS B CHF - ACCUMULATING | CHF | 360,42 | 21.5. | | -4,64 | 7,53 | -14,62 | -24,57 | | A0X8YU | BELLEVUE FUNDS (LUX) - BELLEVUE OBESITY SOLUTIONS B EUR - ACCUMULATING | EUR | 599,94 | 21.5. | | -2,96 | 9,96 | -9,34 | -9,68 | | A0RPSP | BELLEVUE FUNDS (LUX) - BELLEVUE OBESITY SOLUTIONS B USD - ACCUMULATING | USD | 521,23 | 21.5. | | -4,21 | 12,41 | -2,68 | -14,09 | | A0RPSR | BELLEVUE FUNDS (LUX) - BELLEVUE OBESITY SOLUTIONS I CHF - ACCUMULATING | CHF | 410,08 | 21.5. | | -4,38 | 8,29 | -12,80 | -21,87 | | A0RPSQ | BELLEVUE FUNDS (LUX) - BELLEVUE OBESITY SOLUTIONS I EUR - ACCUMULATING | EUR | 681,41 | 21.5. | | -2,70 | 10,73 | -7,42 | -6,46 | | A1JWD8 | BELLEVUE FUNDS (LUX) - BELLEVUE OBESITY SOLUTIONS I GBP - ACCUMULATING | GBP | 464,80 | 21.5. | | -3,67 | 13,41 | -7,95 | -6,05 | | A0X8YS | BELLEVUE FUNDS (LUX) - BELLEVUE OBESITY SOLUTIONS I USD - ACCUMULATING | USD | 589,91 | 21.5. | | -3,95 | 13,21 | -0,60 | -11,02 | | A3E13L | BELLEVUE FUNDS (LUX) - BELLEVUE OBESITY SOLUTIONS I2 CHF - ACCUMULATING | CHF | 128,13 | 21.5. | | -4,33 | 8,44 | - | - | | A2H8LJ | BELLEVUE FUNDS (LUX) - BELLEVUE OBESITY SOLUTIONS I2 EUR - ACCUMULATING | EUR | 159,75 | 21.5. | | -2,64 | 10,88 | -7,06 | -5,81 | | A3E13K | BELLEVUE FUNDS (LUX) - BELLEVUE OBESITY SOLUTIONS I2 USD - ACCUMULATING | USD | 141,27 | 21.5. | | -3,90 | 13,36 | - | - | | 939839 | CANDRIAM EQUITIES L BIOTECHNOLOGY, C - DISTRIBUTION | USD | 1,104,53 | 21.5. | | 4,05 | 55,80 | 54,83 | 59,19 | | 939838 | CANDRIAM EQUITIES L BIOTECHNOLOGY, C - THESAURIERUNG | USD | 1,223,36 | 21.5. | | 4,07 | 55,86 | 54,99 | 59,45 | | A2DLUA | CANDRIAM EQUITIES L BIOTECHNOLOGY, C-H - CAPITALISATION | EUR | 273,70 | 21.5. | | 3,06 | 51,89 | 44,79 | 41,90 | | 692827 | CANDRIAM EQUITIES L BIOTECHNOLOGY, I - CAPITALISATION | USD | 8,214,71 | 21.5. | | 4,33 | 55,56 | 56,62 | 60,40 | | A2DHUX | CANDRIAM EQUITIES L BIOTECHNOLOGY, R - CAPITALISATION | USD | 395,47 | 21.5. | | 4,42 | 57,24 | 59,15 | 66,35 | | A2JCEG | CANDRIAM EQUITIES L BIOTECHNOLOGY, R-H - CAPITALISATION | EUR | 290,20 | 21.5. | | 3,40 | 53,16 | 48,49 | 47,85 | | A0RH1H | CANDRIAM EQUITIES L BIOTECHNOLOGY, V - CAPITALISATION | USD | 3,009,92 | 21.5. | | 4,40 | 55,76 | 57,18 | 61,38 | |
|
|
|
